Industry News

Apr 11, 2018
By BioPharm International Editors
A new study by the Business Research Company reveals prominent contract research organization outsourcing trends.
Apr 11, 2018
By BioPharm International Editors
The agency has assigned new EU member state rapporteurs and co-rapporteurs to medicines previously assigned to the UK’s Medicines and Healthcare products Regulatory Agency.
Apr 11, 2018
By BioPharm International Editors
FDA sent a warning letter to Tris Pharma Inc. after investigators found the company had failed to properly investigate batch failures and establish quality control procedures.
Apr 10, 2018
By BioPharm International Editors
Pharma event announces plans to alternate locations between Indonesia and Thailand to open new market opportunities.
Apr 09, 2018
By BioPharm International Editors
National Institutes of Health researchers use genomics to show that squamous cell carcinomas differ from other cancers, which could advance treatments for head and neck and other cancers.
Apr 06, 2018
By BioPharm International Editors
The European Pharmacopoeia Commission added 19 new monographs and three new chapters and revised 51 monographs and 15 chapters.
Apr 06, 2018
By BioPharm International Editors
On Tuesday, April 24, 2018, Evan Boswell, senior principal scientist at Pfizer CentreOne Contract Manufacturing, Pfizer CentreOne will give a presentation on scaling up the manufacturing process of active pharmaceutical ingredients at CPhI North America in Philadelphia, PA.
Apr 06, 2018
By BioPharm International Editors
Shashank Upadhye, Esq., managing partner at Amin Talati Upadhye, will discuss intellectual property/patent issues for active pharmaceutical ingredients and abbreviated new drug applications at CPhI North America in Philadelphia, PA, on Tuesday, April 24, 2018.
Apr 06, 2018
By BioPharm International Editors
CPhI North America 2018 is hosting a forum for female pharmaceutical professionals to network, collaborate, and share their perspectives at this year’s conference.
Apr 05, 2018
By BioPharm International Editors
The agency’s plan outlines its approach to implementing medical product programs and the use of financial resources.
native1_300x100
lorem ipsum